Yongxin Zhou
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology
- Immunology
- Pulmonary and Respiratory Medicine
- Co-authors
- Shaorui GuChenglai DongZhenchuan LiuKaiqing WuLei LiChang ChenYunlang SheTingting Wang
- Topics
- RNA modifications and cancer (11 papers)Circular RNAs in diseases (7 papers)MicroRNA in disease regulation (6 papers)
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsMolecular Cancer
In The Last Decade
Yongxin Zhou
21 papers receiving 971 citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 801
- Cancer Research 552
- Oncology 124
- Immunology 92
- Pulmonary and Respiratory Medicine 81
Countries citing papers authored by Yongxin Zhou
This map shows the geographic impact of Yongxin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongxin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongxin Zhou more than expected).
Fields of papers citing papers by Yongxin Zhou
This network shows the impact of papers produced by Yongxin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongxin Zhou. The network helps show where Yongxin Zhou may publish in the future.
Co-authorship network of co-authors of Yongxin Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Yongxin Zhou. A scholar is included among the top collaborators of Yongxin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongxin Zhou. Yongxin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 11 | |
| 5 | 16 | |
| 6 | 3 | |
| 7 | N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancerbreakdown → | 267 |
| 8 | 43 | |
| 9 | 10 | |
| 10 | 60 | |
| 11 | 10 | |
| 12 | 69 | |
| 13 | Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axisbreakdown → | 342 |
| 14 | 5 | |
| 15 | 14 | |
| 16 | 3 | |
| 17 | 42 | |
| 18 | 12 | |
| 19 | 11 | |
| 20 | 11 |
About Yongxin Zhou
Yongxin Zhou is a scholar working on Cancer Research, Molecular Biology and Bioengineering, having authored 23 papers that have together received 975 indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (552 citations), Molecular Biology (801 citations) and Oncology (124 citations). Yongxin Zhou has collaborated with scholars based in China, Australia and Germany. Frequent co-authors include Shaorui Gu, Chenglai Dong, Zhenchuan Liu, Kaiqing Wu, Lei Li, Chang Chen, Yunlang She, Tingting Wang, Anquan Shang and Chenzheng Gu. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.